ULYM20030 / ML41690 Polatuzumab / Patrick Reagan
Basic Study Information
Purpose:Location: University of Rochester
The purpose of this study is to test the effectiveness and safety of polatuzumab vedotin
in combination with R-miniCHP in patients 75 years and older with DLBCL.
Lead Researcher (Principal Investigator)
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search